Headquarters: +49 5551 9101 - 00

Mondays to Thursdays: 8 am – 5 am (CET)
Fridays: 8 am – 4 pm (CET)

Send request >

Product advisor

Find the right product

Let our product advisor find the right product for your application.

Find your product >

Product added to compare
Product Compare added Product Compare

New Paper: Investigating the effects of Olaparib on the susceptibility of Glioblastoma

In this paper, Moran et al. examined the potential of Olaparib in combination with natural killer cell therapies in glioblastoma multiforme, a highly invasive and aggressive primary brain malignancy.

Our cellQART 5 micron pore size inserts were used to assess the effects of Olaparib on natural killer cell chemotaxis towards T98G cells.

Read the paper >

Source: Moran, J. et al. Investigating the Effects of Olaparib on the Susceptibility of Glioblastoma Multiforme Tumour Cells to Natural Killer Cell-Mediated Responses. Pharmaceutics 15, 360 (2023).